PE859, a novel curcumin derivative, inhibits amyloid-β and tau aggregation, and ameliorates cognitive dysfunction in senescence-accelerated mouse prone 8

Manuscript Number: 

16-1017R3

Author(s): 
Akinori Akaike, Yuki Fujita, Ichiro Hijikuro, Yasuhiko Izumi, Yukako Kobayashi, Toshiaki Kume, Takaaki Nishimoto, Michiaki Okuda, Hachiro Sugimoto, Takashi Takahashi, Naoki Tanaka, Takuya Uemura, Mei Wada, Tomonori Waku

Disclosures

Akinori Akaike

  • Nothing to Disclose

Yuki Fujita

  • Patents/Royalties
    I am one of the inventors of the substance patent including this compound, but I do not have royalties, serve as an expert witness, nor perform other activities for a commercial sponsor.

Ichiro Hijikuro

  • Nothing to Disclose

Yasuhiko Izumi

  • Nothing to Disclose

Yukako Kobayashi

  • Nothing to Disclose

Toshiaki Kume

  • Nothing to Disclose

Takaaki Nishimoto

  • Nothing to Disclose

Michiaki Okuda

  • Patents/Royalties
    I am one of the inventors of the substance patent including this compound, but I do not have royalties, serve as an expert witness, nor perform other activities for a commercial sponsor.

Hachiro Sugimoto

  • Patents/Royalties
    I am one of the inventors of the substance patent including this compound, but I do not have royalties, serve as an expert witness, nor perform other activities for a commercial sponsor.

Takashi Takahashi

  • Nothing to Disclose

Naoki Tanaka

  • Nothing to Disclose

Takuya Uemura

  • Nothing to Disclose

Mei Wada

  • Nothing to Disclose

Tomonori Waku

  • Nothing to Disclose